Hematopoietic tablets and ferrous succinate can be used for the treatment of iron deficiency anemia, the effect of medication varies from person to person, can not be compared as a whole, the specific use of medication as prescribed by the doctor.
Blood-sourcing tablets have the effect of benefiting qi and tonifying blood, applicable to iron deficiency anemia is a deficiency of qi and blood, the specific symptoms include lack of spirit, weakness, dizziness, tinnitus, face, skin yellow or pale, palpitations, shortness of breath, pale or fat tongue, weak pulse, and so on.
The contraindications for the use of this drug are not clear. Adverse reactions such as epigastric discomfort, nausea, increased frequency of bowel movements, skin rash may occur after use of the drug. During the period of taking the drug, pay attention to review the blood routine, serum iron and other related biochemical indicators.
Ferrous Succinate Tablets are indicated for the prevention and treatment of iron deficiency anemia. Contraindications include severe impairment of hepatic and renal function, patients with iron overload, hemochromatosis or ferrous hemosiderosis, patients with non-iron-deficiency anemia, especially those with untreated urinary tract infections. Adverse reactions such as nausea, vomiting, epigastric pain, constipation and black stools have been seen after administration.
Hematopoietic tablets and ferrous succinate have certain therapeutic effects on iron deficiency anemia, but there is individual variability in the use of drugs, so both drugs have their own suitable for the use of the population, can not be unified as a whole to explain which drug is better. The specific use of drugs should be carried out under the guidance of a specialist physician, not unauthorized use of drugs.